James X.

Investor in Mining and Commodities

📍 Xuhui District, Shanghai, China🔄 Updated September 2026💼 2 investments📅 9 years investing🗓 Last invested Jul 2017
VC🌍 China
2
Total investments
1
Early stage
0
Mid stage
1
Late stage
9y
Years active

Portfolio

2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Jul 2017
Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence. Currently, Potrero Medical is developing a predictive health platform to help medical teams better predict adverse outcomes in critical care settings. The Accuryn® Monitoring System is not cleared for prediction of disease states or clinical conditions.
Investor
Jul 2017
...
Experience · 7 entries
All (7)
Investments (2)
Founder (1)
2017
Managing Partner
Aug 2017
X Square Capital (“X2Capital”) is a China based investment firm, backed by a group of industrial family offices from Ningbo, Zhejiang, a leading industrial city in Eastern China with the world’s largest port and largest petrochemical manufacturing base. X2Capital has five offices in Ningbo, Shanghai, Hong Kong, Conakry, and Dubai, with a team of ex-investment bankers, consultants, senior advisors from our focused sectors. Our focus on sectors is at the core of our investment strategy. Our investments are principally organized around four sectors: Manufacturing, Metal & Mining, Petrochemicals and Healthcare. Over the last couple of years, X2Capital viewed Middle East as the most important overseas market to expand our petrochemical and mineral processing portfolio, with a focus on exploring opportunities connecting Middle East’s rich natural resources and China’s tremendous market potential.
X Square Capital
Co-Founder & Managing Partner
Aug 2017
Investor
Jul 2017
Potrero Medical is a predictive health company that is developing the next generation of smart sensors and artificial intelligence. Currently, Potrero Medical is developing a predictive health platform to help medical teams better predict adverse outcomes in critical care settings. The Accuryn® Monitoring System is not cleared for prediction of disease states or clinical conditions.
Investor
Jul 2017
...
2014
Managing Director, Head of North China Corporates & Head of China Oil & Gas/Petrochemical
Aug 2014
We are a leading international banking group, with a presence in 54 of the world’s most dynamic markets. Our purpose is to drive commerce and prosperity through our unique diversity, and our heritage and values are expressed in our brand promise, here for good. If you’re interested joining Standard Chartered sign up to our Talent Network. Link: https://www.sc.com/careers/talentnetwork Standard Chartered PLC is listed on the London and Hong Kong stock exchanges.
Show all 7 entries ↓